RECRUITING

Cognitive Training Intervention and Attitudes Towards Genetics

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HCT) survivors using the cognitive training Lumosity program. In addition, patients' interest in receiving information regarding genetic risk of cognitive impairment post-HCT will be measured.

Official Title

Intervention Strategies to Improve Cognitive Functioning in Hematologic Cancer Survivors After Hematopoietic Cell Transplantation

Quick Facts

Study Start:2017-08-21
Study Completion:2025-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03094026

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * ≥ 21 years old at time of allogeneic HCT performed at UAB
  2. * Outpatient and between 3 and 6 months post HCT
  3. * English speaking
  4. * Possess access to an internet-connected home computer
  1. * History of pre-existing neurological disorder or documented major psychiatric disorder; significant auditory, visual, or motor impairments
  2. * Participated in neuropsychological intervention within the past 6 months
  3. * History of color blindness

Contacts and Locations

Study Contact

Noha M Sharafeldin, MD,MSc, PhD
CONTACT
2056382144
nsharaf@uab.edu
Lindsey Hageman, MPH
CONTACT
2056382139
lhageman@peds.uab.edu

Principal Investigator

Noha M Sharafeldin
PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham

Study Locations (Sites)

University of Alabama at Birmingham
Birmingham, Alabama, 35233
United States

Collaborators and Investigators

Sponsor: University of Alabama at Birmingham

  • Noha M Sharafeldin, PRINCIPAL_INVESTIGATOR, University of Alabama at Birmingham

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2017-08-21
Study Completion Date2025-07

Study Record Updates

Study Start Date2017-08-21
Study Completion Date2025-07

Terms related to this study

Keywords Provided by Researchers

  • Hematologic cancers
  • Hematopoietic cell transplantation
  • cognitive training
  • genetic knowledge
  • genetic attitude
  • adult cancer survivors

Additional Relevant MeSH Terms

  • Cognitive Impairment
  • Hematologic Neoplasms
  • Hematopoietic Cell Transplant